Bard IVC Filter Failure Claims Now Being Reviewed by Resource4thePeople Attorneys

Share Article

As the number of inquiries from concerned consumers increases, Resource4thePeople announces free consultations to evaluate allegations from patients who may have suffered serious health problems involving alleged failures of Bard IVC Filters.

http://www.resource4thepeople.com/defectivemedicaldevices/bard-ivc.html

Resource4thePeople announced today that its attorneys are now investigating claims from victims who allegedly may have suffered serious health problems as a result of Bard IVC Filter failures.

“Our lawyers are now actively investigating these claims and stand ready to provide consultations in which the legal options available to seek compensation in such cases can be provided to consumers,” said Resource4thePeople.

“Recent developments that have put the safety of these devices in question and generated an increase in consumer inquiries include the announcement of a reevaluation from medical professionals and increasing numbers of Adverse Event Reports compiled by the Food and Drug Administration.”

Resource4thePeople also announced that it will be updating the information bank on its web site to include these developments and other news reports, medical research findings and FDA warnings about the safety of the Bard IVC Filter.

The professional review was launched by The Society of Interventional Radiology and Society for Vascular Surgery,* which said that it will form a task force to measure the health risk of IVC filters to patients.

The Food and Drug Administration also has warned** about increasing numbers of Adverse Event Reports detailing risks involved with the use of the devices.

"The fact that a respected medical society and the FDA are both raising concerns about the safety of IVC filters has generated a great deal of patient concern and questions to us about the availability of legal advice," said Resource4thePeople.

"One of the devices mentioned frequently in the listing of over 900 Adverse Event Reports is the C.R. Bard Filter. In response to these inquiries from consumers we are providing links to lawyers who are offering free consultations."

These consultations are now being offered to provide consumers with a comprehensive review of the legal options that may be available to them to seek compensation for medical costs, pain and suffering and other expenses related to an IVC failure, said Resource4thePeople.

IVC filters -- inferior vena cava filters -- are medical devices that are designed to prevent blood clots in patients at risk for a pulmonary embolism in cases in which an anticoagulant is contraindicated or proven ineffective.

The FDA's warning issued to health care professionals and consumers reports that serious health problems can occur on these spider-like devices when the legs that extend from it to block clots break off.

What can then occur, according to the FDA is that these broken parts from the filter may travel to other parts of the body and cause serious problems such as lower limb deep vein thrombosis (DVT), filter fracture, filter migration, filter embolization and IVC perforation.

The Bard IVC Filter information bank link is:

http://www.resource4thepeople.com/defectivemedicaldevices/bard-ivc.html

For instance, class-action lawsuits were recently filed by patients who had Bard IVC filters implanted in their bodies and claim to have suffered serious health problems.***

The lawsuits allege that the devices are prone to fracture and cause tears in body organs, including the heart and that C.R. Bard is liable because company officials were aware of IVC filters problems but failed to adequately warn patients and health care professionals.

The lawsuit claims that an estimated 100,000 of the devices have been implanted in patients in the United States.

These lawsuits and the medical society’s formation of an IVC filter follow the warning issued by the FDA detailing the large number of Adverse Event Reports:

"Since 2005, the FDA has received 921 device adverse event reports involving IVC filters, of which 328 involved device migration, 146 involved embolizations (detachment of device components), 70 involved perforation of the IVC, and 56 involved filter fracture. Some of these events led to adverse clinical outcomes in patients. These types of events may be related to a retrievable filter remaining in the body for long periods of time, beyond the time when the risk of pulmonary embolism (PE) has subsided.

"The FDA is concerned that these retrievable IVC filters, intended for short-term placement, are not always removed once a patient’s risk for PE subsides. Known long term risks associated with IVC filters include but are not limited to lower limb deep vein thrombosis (DVT), filter fracture, filter migration, filter embolization and IVC perforation."

The FDA recommended that health care professionals responsible for the ongoing care of patients with retrievable IVC filters consider removing the filter as soon as protection from pulmonary embolisms is no longer needed.

The agency also said that it is continuing to review the medical research about IVC filter problems and would issue an updated report when more information becomes available.

Consumer4thePeople is also recommending that patients who have had IVC filters implanted in their bodies research the FDA's Adverse Event Reports files, which are public record.

Resource4thePeople also is announcing its support for The Society of Interventional Radiology and Society for Vascular Surgery's announcement of the formation of a medical review -- PRESERVE -- to analyze the health risk of IVC filters to patients and is encouraged by the following mission statement issued by the group:

"PRESERVE data will allow a systematic, functional view, representative of all filters placed in the United States, thus, all stakeholders—individuals, health care professionals, insurers and government regulators—will be armed with the knowledge they need on patient risk and, subsequently, quality improvement in filter placement, management and retrieval," said SIR President Marshall E. Hicks, M.D.

sources:
*http://www.sirweb.org/news/newsPDF/Release_PRESERVE_Final_.pdf
**http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm221707.htm
***First Judicial District of Pennsylvania, In the Court of Common Pleas, Philadelphia County; Case ID120800814

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Bill Callahan
iLawSuit
858 602-2749
Email >
Visit website